Limbic and nigral lewy bodies and Alzheimer's disease pathology mimicking progressive supranuclear palsy in a 75-year-old man with preserved cardiac uptake of MIBG

Journal of Alzheimer's Disease

Volumn 32, Issue 4, 2012, Pages 889-894

  Kasahata, Naoki ^a,b   Uchihara, Toshiki ^c   Orimo, Satoshi ^d   Nakamura, Ayako ^c   Makita, Yoshihisa ^a  

^a Makita General Hospital   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d Mutual Aid Association of Public School Teachers   (Japan)

Author keywords

Alzheimer disease; Lewy body; limbic system; MIBG; progressive supranuclear palsy (PSP)

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CARBIDOPA; LEVODOPA;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN ATROPHY; CASE REPORT; DEMENTIA; DYSPHASIA; HUMAN; HUMAN TISSUE; LEWY BODY; LOCUS CERULEUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SUBSTANTIA NIGRA;

EID: 84872287923     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120445     Document Type: Article

References (28)

1. Duvoisin RC (1994) Differential diagnosis of PSP. J Neural Transm Suppl 42, 51-67.
2. Arnold G, Tatsch K, Oertel WH, Vogl T, Schwarz J, Kraft E, Kirsch CM (1994) Clinical progressive supranuclear palsy: differential diagnosis by IBZM-SPECT and MRI. J Neural Transm Suppl 42, 111-118.
3. Fearnley JM, Revesz T, Brooks DJ, Frackowiak RSJ, Lees AJ (1991) Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry 54, 159-161.
4. de Bruin VMS, Lees AJ, Daniel SE (1992) Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: A case report. Move Disord 7, 355-358.
5. Kasahata N, Uchihara T, Nakamura A, Miyazawa Y, Kamei T (2012) A 71-year-old woman with PSP-like symptoms. Brain Pathol, in press.
6. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallet M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olzewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 47, 1-9.
7. Kato N, Arai K, Hattori T (2003) Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 210, 57-60.
8. Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, Furui S, Shimizu T, Uchigata M, Matsumura K, Sonoo M, Sakai M, Takada K, Harasawa A, Takeshita K, Kohtake H, Tanaka H, Suzuki S (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64, 2050-2055.
9. Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 67, 189-194.
10. Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, Tsuchiya K, Mori F, Wakabayashi K, Takahashi H (2005) Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol 109, 583-588.
11. Uchihara T (2007) Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol 113, 483-499.
12. Uchihara T, Hara M, Nakamura A, Hirokawa K (2012) Tangle evolution linked to differential 3-and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies. Histochem Cell Biol 137, 261-267.
13. Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T (2011) Pale neurites, premature-synuclein aggregates with centripetal extension from axon collaterals. Brain Pathol 22, 67-78.
14. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lenox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH, for the Consortium on Dementia with Lewy Bodies (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47, 1113-1124.
15. Braak H, Tredici KD, R̈ub U, de Vos RAI, Steur ENHJ, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24, 197-211.
16. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128, 1247-1258.
17. Ishino H, Otsuki S (1975) Distribution of Alzheimer's neurofibrillary tangles in the basal ganglia and brain stem of progressive supranuclear palsy and Alzheimer's disease. Folia Psychiatr Neurol Jpn 29, 179-187.
18. Mattila P, Togo T, Dickson DW (2002) The subthalamic nucleus has neurofibrillary tangles in argyrophilic grain disease and advanced Alzheimer's disease. Neurosci Lett 320, 81-85.
19. Urasaki K, Kuriki K, Namerikawa M, Satoh S, Ikeguchi K, Fukayama M, Saito K, Nakano I (2000) An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap. Neuropathology 20, 233-238.
20. Morris JC, Drazner M, Fulling K, Grant EA, Goldring J (1989) Clinical and pathological aspects of parkinsonism in Alzheimer's disease. Arole for extranigral factors? Arch Neurol 46, 651-657.
21. Yokota O, Tsuchiya K, Uchihara T, Ujike H, Terada S, Takahashi M, Kimura Y, Ishizu H, Akiyama H, Kuroda S (2007) Lewy body variant of Alzheimer's disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem. Neuropathology 27, 21-35.
22. Rezaie P, Cairns NJ, Chadwick A, Lantos PL (1996) Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett 212, 111-114.
23. Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of-synucleinopathy. Relevance in a population-based cohort. Neurology 70, 1042-1048.
24. Weisman D, Cho M, Taylor C, Adame A, Thal LJ, Hansen LA (2007) In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology 69, 356-359.
25. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VMY, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, for the Consortium on DLB (2005) Diagnosis and management of dementia with Lewy bodies: Third report of theDLBConsortium. Neurology 65, 1863-1872.
26. Lopez OL, Hamilton RL, Becker JT, Wisniewski S, Kaufer DI, DeKosky ST (2000) Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 54, 1780-1787.
27. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, and participating CERAD neuropathologists (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
28. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 18(4 Suppl), S1-S2.